Skip to main content

Animations

MJFF Publications

5841 - 5850 of 9140 Results
Title
Year
  • Year
  • 2015
  • 2024
  • 2018
  • 2018
  • 2022
  • 2015
  • 2021
  • 2026
  • 2019
  • 2017
  • Summary Details
    OPEN
    Title: Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damage
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.13242
    Citation Count: 72
  • Summary Details
    RESTRICTED
    Title: Symmetry of synuclein density in autopsied Parkinson’s disease submandibular glands
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2024.137702
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease
    Journal Name: PeerJ
    Publisher: PeerJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7717/peerj.5539
    Citation Count: 19
  • Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study
    2018
    Summary Details
    RESTRICTED
    Title: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ane.13028
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoids
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.202107135
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor
    Journal Name: ACS Medicinal Chemistry Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study
    Journal Name: The Lancet Regional Health - Americas
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.lana.2021.100136
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Methods to Study the Molecular Mechanism and Drive the Design of Protein Degraders
    Journal Name: Chemical Reviews
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.chemrev.5c00800
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION
    Journal Name: Molecular Genetics & Genomic Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mgg3.564
    Citation Count: 94
  • Summary Details
    RESTRICTED
    Title: MitoNEET (CISD1) Knockout Mice Show Signs of Striatal Mitochondrial Dysfunction and a Parkinson’s Disease Phenotype
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00287
    Citation Count: 95
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.